Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119930) titled 'Validation Study on the Concordance Between Drug Sensitivity Testing in Advanced NSCLC Tumor Organoid-Immune Cell Co-cultures and the Clinical Efficacy of Immune Checkpoint Inhibitors' on March 5.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Second Affiliated Hospital of Xi'an Jiaotong University
Condition:
Non-small cell lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-05
Target Sample Size: Non-small cell lung cancer observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...